BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22617307)

  • 1. [The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial].
    Galeone G; Spadavecchia R; Balducci MT; Pagliarulo V
    Minerva Urol Nefrol; 2012 Jun; 64(2):135-41. PubMed ID: 22617307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pumpkin seeds, Centella asiatica, Boswellia, Helichrysum, acetate vitamin E, Melaleuca alternifolia and hyaluronic acid phytocomplex monotherapy effects in patients with chronic pelvic pain syndrome.
    Di Vico T; Durante J; Polito C; Tognarelli A; Canale D; Caglieresi C; Morelli G; Bartoletti R
    Minerva Urol Nefrol; 2020 Apr; 72(2):236-242. PubMed ID: 31558010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of Boswellia resin extract and propolis derived polyphenols can improve quality of life in patients affected by prostatitis-like symptoms.
    Sibona M; Destefanis P; Agnello M; Lillaz B; Giuliano M; Cai T; Gontero P
    Arch Ital Urol Androl; 2020 Jan; 91(4):251-255. PubMed ID: 31937091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
    Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
    Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
    Morgia G; Russo GI; Urzì D; Privitera S; Castelli T; Favilla V; Cimino S
    Arch Ital Urol Androl; 2017 Jun; 89(2):110-113. PubMed ID: 28679180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis.
    Stamatiou K; Magri V; Perletti G; Trinchieri A; Lacroix R; Rekleiti N; Moschouris H
    Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study of prostat combined with an antibiotic for chronic nonbacterial prostatitis].
    Ye ZQ; Lan RZ; Wang SG; Cai SL; Chen GM; Li NC; Song Y; Na YQ
    Zhonghua Nan Ke Xue; 2006 Sep; 12(9):807-10. PubMed ID: 17009533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pollen extract in association with vitamins (DEPROX 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study.
    Cai T; Luciani LG; Caola I; Mondaini N; Malossini G; Lanzafame P; Mazzoli S; Bartoletti R
    Urologia; 2013 Apr; 80 Suppl 22():5-10. PubMed ID: 23334883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis].
    Monden K; Tsugawa M; Ninomiya Y; Ando E; Kumon H
    Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):539-47. PubMed ID: 12056038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS; Parikh A
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Cai T; Mazzoli S; Bechi A; Addonisio P; Mondaini N; Pagliai RC; Bartoletti R
    Int J Antimicrob Agents; 2009 Jun; 33(6):549-53. PubMed ID: 19181486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis.
    Altintas R; Oguz F; Beytur A; Ediz C; Gunes A; Ozer A
    Actas Urol Esp; 2013; 37(10):619-24. PubMed ID: 23768504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and tolerability of pollen extract in combination with hyaluronic acid and vitamins in the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome: a 26 weeks, randomized, controlled, single-blinded, phase III study.
    Cai T; Gallelli L; Cione E; Verze P; Palmieri A; Mirone V; Bonkat G; Wagenlehner FM; Bjerklund Johansen TE
    Minerva Urol Nephrol; 2022 Dec; 74(6):780-788. PubMed ID: 33781014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
    Busetto GM; Giovannone R; Ferro M; Tricarico S; Del Giudice F; Matei DV; De Cobelli O; Gentile V; De Berardinis E
    BMC Urol; 2014 Jul; 14():53. PubMed ID: 25038794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Flogofilm
    Barone B; Mirto BF; Falcone A; Del Giudice F; Aveta A; Napolitano L; Del Biondo D; Ferro M; Busetto GM; Manfredi C; Terracciano D; Gambardella R; Pandolfo SD; Trama F; De Luca C; Martino R; Capone F; Giampaglia G; Sicignano E; Tataru OS; Lucarelli G; Crocetto F
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective interventional study in chronic prostatitis with emphasis to clinical features.
    Stamatiou KN; Moschouris H
    Urol J; 2014 Sep; 11(4):1829-33. PubMed ID: 25194085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
    Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.